| Mark Melgaard, RPH | |
|
1017 Nevada Way, Boulder City, NV 89005-1801 | |
| (702) 293-6705 | |
| Not Available |
| Full Name | Mark Melgaard |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1017 Nevada Way, Boulder City, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144825647 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15674 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark Melgaard, RPH 684 Vortex Ave, Henderson, NV 89002-6563 Ph: () - | Mark Melgaard, RPH 1017 Nevada Way, Boulder City, NV 89005-1801 Ph: (702) 293-6705 |
News Archive
Outcome Sciences, Inc. (OUTCOME), the leading provider of patient registries, studies, and technologies for evaluating real-world outcomes, today announced that the Agency for Healthcare Research and Quality (AHRQ) has selected Outcome as the DEcIDE Center for a study designed to compare the effectiveness of medications versus surgery for the treatment of open-angle glaucoma. The study will enroll 2,600 patients from 30 sites across the United States and is intended to provide new scientific information about the effects of different treatment approaches in individuals who have glaucoma.
Medtronic plc announced FDA approval and U.S. launch of the Intellis(TM) platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the EvolveSM workflow*, which standardizes guidance and balances high-dose (HD) and low-dose (LD) therapy settings.
Scientists have uncovered the mechanism that controls whether cells that are able to suppress immune responses live or die.
Lung cancer takes a heavy toll, contributing to more cancer deaths in the United States each year than breast, prostate and colon cancers combined. Contributing to this poor prognosis is the fact that lung cancer often goes undetected until the disease has reached an advanced and more difficult-to-treat stage.
› Verified 6 days ago
Sheryl Rose, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1031 Nevada Hwy, Boulder City, NV 89005 Phone: 702-293-6347 Fax: 702-293-6274 | |
Mrs. Sharlene Ann Mcneil Philpott, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1031 Nevada Hwy, Boulder City, NV 89005 Phone: 702-293-6347 Fax: 702-293-6274 | |
Mr. John Revolinski, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1521 Mancha Dr, Boulder City, NV 89005 Phone: 213-300-2438 | |
Hitesh R Amin, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Sav-on Pharmacy, 1008 Nevada Way, Boulder City, NV 89005 Phone: 702-293-7592 Fax: 702-293-7606 | |
Ashlie Simon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1017 Nevada Way, Boulder City, NV 89005 Phone: 702-293-6705 | |
Ramona Kristina Sirgedas, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 643 Florence Dr, Boulder City, NV 89005 Phone: 702-994-9012 |